Since COVID-19 vaccine distribution began in December 2020, millions of people across the United States have been vaccinated.  Still, a large percentage of people remain unvaccinated, which creates challenges for employers who view the COVID-19 vaccine as a key protective measure for maintaining a safe and healthy workplace.

Drug testing in the workplace, especially in the manufacturing industry, has become a common part of pre-employment screening and health/safety measures in the workplace, which may include random, post-accident, and reasonable-suspicion testing.  

OSHA’s recent enforcement activity serves as a reminder to employers across all industries of the obligation to record work-related COVID-19-related infections, hospitalizations and fatalities. An employer’s failure to comply with OSHA’s recordkeeping and reporting requirements could result in significant penalties.